London hosts 40% of UK healthtech startups, with $4.9B in aggregate funding. These 17 investors are actively backing digital health and medtech companies in 2026.
London is Europe's leading hub for digital health, with 202 healthtech startups based here. Funding hit $4B across Europe and the US in Q1 2026.
The money in 2026 is concentrated in AI-enabled health. Just 12 companies captured 59% of Q1 funding, mostly AI-native platforms with clinical evidence.
What gets funded now: workflow-embedded clinical tools, EHR-integrated software, and digital therapeutics. Wellness apps without outcomes data rarely raise.
Set up an Ellty data room with your clinical evidence, ARR, and regulatory docs first. London healthtech investors ask for proof fast.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| Octopus Ventures | Multi-stage VC | £100K-£10M | Digital health, medtech, B2B | octopusventures.com |
| AlbionVC | Health-specialist VC | £2M-£10M | Digital care, clinical AI, health infra | albion.vc |
| Sofinnova Partners | Life sciences VC | €5M-€50M+ | Medtech, biotech, digital health | sofinnovapartners.com |
| Balderton Capital | Series A-B VC | £2M-£15M | Digital health, clinical trials, SaaS | balderton.com |
| GHO Capital | Healthcare growth PE | €50M+ | Healthcare, digital health, services | ghocapital.com |
| Apposite Capital | Healthcare VC | £2M-£15M | Digital health, diagnostics, medtech | appositecapital.com |
| MMC Ventures | Multi-stage VC | Seed to Series B | Healthtech, AI, B2B SaaS | mmc.vc |
| Hambro Perks | Early-stage VC | £500K-£5M | Healthtech, deep tech, software | hambroperks.com |
| Seedcamp | European seed fund | Pre-seed to seed | Healthtech, AI, SaaS | seedcamp.com |
| Firstminute Capital | Seed VC | £500K-£3M | Healthtech, AI, consumer | firstminute.capital |
| LocalGlobe | Seed VC | £200K-£2M | Healthtech, consumer, enterprise | localglobe.vc |
| Entrepreneur First | Company builder | £80K-£150K initial | Healthtech, deep tech, AI | joinef.com |
| Calm/Storm Ventures | Healthtech seed VC | €150K-€1M | Digital health, femtech, prevention | calmstorm.vc |
| Nina Capital | Healthtech seed VC | €250K-€1.5M | Health tech, deep tech for health | nina.capital |
| Hoxton Ventures | Seed VC | £500K-£3M | Healthtech, enterprise, consumer | hoxtonventures.com |
| Heal Capital | Digital health VC | €1M-€8M | Digital health, medtech, care | healcapital.com |
| Octopus + Tenx Health | Health growth fund | £5M-£20M | Digital health, health systems | octopusventures.com |
See which healthtech VCs open your pitch
Build an Ellty data room. Send trackable links to London healthtech investors.
Start free 14-day trialWhat is a London healthtech investor?
A London healthtech investor backs companies building digital health, medtech, and care software. They range from health-specialist funds to generalist VCs with a health pod.
The specialists differ from generalist VCs in one way: they understand clinical evidence and NHS procurement. They know what a real outcome study looks like.
Check sizes run from £80K at Entrepreneur First to €50M+ at GHO Capital. Most early healthtech rounds in London land between £500K and £10M.
The NHS shift to value-based procurement in 2026 raised the bar. Read what investors look for in a data room and compare London fintech investors on diligence depth.
The healthtech companies raising in 2026 are the ones embedding into clinical workflows and proving outcomes. Wellness apps without evidence don't get a second meeting.
17 top London healthtech investors
1. Octopus Ventures
Octopus is one of London's most active healthtech investors, with a dedicated Future of Health pod. They back digital health from pre-seed to Series A with £100K-£10M checks.
- Recent Deals: Active digital health portfolio; backed Big Health, Vira Health, Alba Health; £200M+ deployed annually; 2026 active
- LinkedIn: Octopus Ventures LinkedIn
- Sector Focus: Digital health, medtech, B2B software, fintech
- Stage Focus: Pre-seed to Series A (£100K-£10M)
- Location: London, UK
- Website: octopusventures.com
2. AlbionVC
AlbionVC is a London health-specialist VC backing digital care, clinical decision support, and healthcare AI. They focus on Series A in European healthcare AI and digital care.
- Recent Deals: Active European healthcare AI portfolio; digital care and clinical AI focus; Series A mandate; 2025-2026 active
- LinkedIn: AlbionVC LinkedIn
- Sector Focus: Digital care, clinical AI, healthcare infrastructure
- Stage Focus: Series A (£2M-£10M)
- Location: London, UK
- Website: albion.vc
3. Sofinnova Partners
Sofinnova is a leading European life sciences VC with over €4B in AUM and a London office. They back medtech, biotech, and healthtech across six investment strategies.
- Recent Deals: Active European medtech and healthtech portfolio; €4B+ AUM; London, Milan, Paris offices; 2025-2026 active
- LinkedIn: Sofinnova Partners LinkedIn
- Sector Focus: Medtech, biotech, digital health, life sciences
- Stage Focus: Seed to growth (€5M-€50M+)
- Location: London and Paris
- Website: sofinnovapartners.com
4. Balderton Capital
Balderton led Lindus Health's $55M Series B in 2025 - a London clinical-trials platform. They back digital health and health software at Series A and B.
- Recent Deals: Lindus Health $55M Series B lead (2025); active European health portfolio; Series A to B mandate; 2026 active
- LinkedIn: Balderton Capital LinkedIn
- Sector Focus: Digital health, clinical trials, health SaaS
- Stage Focus: Series A to Series B (£2M-£15M)
- Location: London, UK
- Website: balderton.com
5. GHO Capital
GHO is a London healthcare growth investor that boosted its fund to €2.5B in 2025. They back later-stage digital health and healthcare services companies.
- Recent Deals: €2.5B fund (boosted 25% in October 2025); active healthcare growth portfolio; transatlantic mandate; 2026 active
- LinkedIn: GHO Capital LinkedIn
- Sector Focus: Healthcare, digital health, healthcare services
- Stage Focus: Growth equity (€50M+)
- Location: London, UK
- Website: ghocapital.com
Share your healthtech deck with trackable links
Use Ellty to send your deck. Know when London healthtech investors open it.
Start free 14-day trial6. Apposite Capital
Apposite is a London healthcare specialist backing medical products, diagnostics, and digital health. They address the shortage of scale-up capital for UK health companies.
- Recent Deals: Active UK healthcare scale-up portfolio; diagnostics and digital health focus; growth capital mandate; 2025-2026 active
- LinkedIn: Apposite Capital LinkedIn
- Sector Focus: Digital health, diagnostics, medtech, life sciences tools
- Stage Focus: Growth (£2M-£15M)
- Location: London, UK
- Website: appositecapital.com
7. MMC Ventures
MMC is a London multi-stage VC backing healthtech among AI and B2B software. They invest from seed through Series B with a long follow-on runway.
- Recent Deals: Active London healthtech and AI portfolio; seed to Series B mandate; UK-focused; 2025-2026 active
- LinkedIn: MMC Ventures LinkedIn
- Sector Focus: Healthtech, AI, B2B SaaS, fintech
- Stage Focus: Seed to Series B
- Location: London, UK
- Website: mmc.vc
8. Hambro Perks
Hambro Perks is a London early-stage fund backing healthtech and software founders. They write £500K-£5M and support companies through commercial scaling.
- Recent Deals: Active London healthtech and software portfolio; early-stage mandate; UK and global focus; 2025-2026 active
- LinkedIn: Hambro Perks LinkedIn
- Sector Focus: Healthtech, deep tech, software
- Stage Focus: Seed to Series A (£500K-£5M)
- Location: London, UK
- Website: hambroperks.com
9. Seedcamp
Seedcamp is one of Europe's most active seed funds with strong healthtech deal flow. They co-invested in Lindus Health and back health founders at first-check stage.
- Recent Deals: Lindus Health backer; 492 portfolio companies; active healthtech seed deal flow; 2025-2026 active
- LinkedIn: Seedcamp LinkedIn
- Sector Focus: Healthtech, AI, SaaS, software
- Stage Focus: Pre-seed to seed
- Location: London, UK
- Website: seedcamp.com
10. Firstminute Capital
Firstminute is a London seed fund backed by unicorn founders and a Lindus Health investor. They write £500K-£3M into healthtech and AI founders early.
- Recent Deals: Lindus Health backer; 150+ portfolio companies; unicorn founder network; 2025-2026 active
- LinkedIn: Firstminute Capital LinkedIn
- Sector Focus: Healthtech, AI, consumer, B2B software
- Stage Focus: Seed (£500K-£3M)
- Location: London, UK
- Website: firstminute.capital
11. LocalGlobe
LocalGlobe is one of London's most active seed funds and writes first checks into healthtech. They back companies before most institutional funds engage.
- Recent Deals: Active London seed portfolio; 25 investments in 2025; healthtech and tech focus; 2026 active
- LinkedIn: LocalGlobe LinkedIn
- Sector Focus: Healthtech, consumer tech, enterprise SaaS
- Stage Focus: Pre-seed to seed (£200K-£2M)
- Location: London, UK
- Website: localglobe.vc
12. Entrepreneur First
Entrepreneur First is a company builder that backs individual healthtech founders early. Several health companies have been built through its London cohorts.
- Recent Deals: Active London cohorts 2025-2026; built companies worth $10B+ in aggregate; healthtech founders backed; 10+ per cohort
- LinkedIn: Entrepreneur First LinkedIn
- Sector Focus: Healthtech, deep tech, AI - individual talent focus
- Stage Focus: Pre-company to pre-seed (£80K-£150K initial)
- Location: London, UK
- Website: joinef.com
13. Calm/Storm Ventures
Calm/Storm is a healthtech-focused seed fund active in London with a €30M fund. They back prevention, femtech, and digital health founders very early.
- Recent Deals: €30M healthtech fund (2025); active European digital health portfolio; femtech and prevention focus; 2026 active
- LinkedIn: Calm/Storm Ventures LinkedIn
- Sector Focus: Digital health, femtech, prevention
- Stage Focus: Pre-seed to seed (€150K-€1M)
- Location: London and Vienna
- Website: calmstorm.vc
14. Nina Capital
Nina Capital is a seed-stage VC exclusively dedicated to healthtech, active across Europe. They back deep-tech-for-health founders at the earliest stage.
- Recent Deals: Active European healthtech seed portfolio; deep tech for health focus; seed mandate; 2025-2026 active
- LinkedIn: Nina Capital LinkedIn
- Sector Focus: Health tech, deep tech for health
- Stage Focus: Seed (€250K-€1.5M)
- Location: London and Barcelona
- Website: nina.capital
15. Hoxton Ventures
Hoxton is one of London's most accessible seed funds and an active healthtech backer. They write £500K-£3M into early health and software companies.
- Recent Deals: Active London healthtech and software portfolio; 90 portfolio companies; pre-seed to seed; 2026 active
- LinkedIn: Hoxton Ventures LinkedIn
- Sector Focus: Healthtech, enterprise software, consumer tech
- Stage Focus: Pre-seed to seed (£500K-£3M)
- Location: London, UK
- Website: hoxtonventures.com
16. Heal Capital
Heal Capital is a digital health VC active in the London and European market. They back digital health, medtech, and care companies at Series A.
- Recent Deals: Active European digital health portfolio; medtech and care focus; Series A mandate; 2025-2026 active
- LinkedIn: Heal Capital LinkedIn
- Sector Focus: Digital health, medtech, care delivery
- Stage Focus: Series A (€1M-€8M)
- Location: London and Berlin
- Website: healcapital.com
17. Octopus Ventures Tenx Health
Octopus expanded its health offering with the Tenx Health team and a global fund. The fund backs later-stage digital health and health-systems companies.
- Recent Deals: Tenx Health team and global fund launch; later-stage digital health focus; health systems mandate; 2025-2026 active
- LinkedIn: Octopus Ventures LinkedIn
- Sector Focus: Digital health, health systems, care delivery
- Stage Focus: Growth (£5M-£20M)
- Location: London, UK
- Website: octopusventures.com
What healthtech investors check first
London healthtech investors check clinical evidence before anything else. The first question is whether your outcomes data holds up to a clinician's scrutiny.
The second filter is regulatory path. MHRA and EU AI Act positioning are standard asks for any health AI product in 2026.
The third is NHS or payer route. With value-based procurement live, investors want a clear path to a paying health system.
Use Ellty to share clinical studies and regulatory docs securely. Read HR due diligence to prepare the team and compliance side reviewers check.
How NHS procurement shapes your raise
The NHS moved to value-based procurement in 2026, which changes what investors want to see. They expect proof your product improves an outcome, not just usage.
A signed NHS pilot or framework place is the strongest signal at Series A. Without it, most London health VCs will wait for one before committing.
Build your evidence pack early. Read how to organize a data room for VC fundraising before you approach any health-specialist fund.
Where London healthtech founders meet investors
HLTH Europe, the Healthtech Summit, and Digital Health World Congress are where these investors appear. University spinout networks also matter.
The Golden Triangle of London, Oxford, and Cambridge feeds most UK health deals. A warm intro from a clinician or portfolio founder beats a cold email.
Compare how England investors operate nationally versus London health specialists. Have your Ellty data room ready before any event.
How to pitch a London healthtech investor
Four steps for healthtech fundraising in 2026. Each one is specific to how health investors read deals.
- 1.Lead with clinical evidence, not featuresOpen with your outcome data, not your UI. Health investors check whether a clinician would trust it.
- 2.Show a clear regulatory pathMHRA and AI Act questions are standard now. Have a two-line answer ready before any first call.
- 3.Prove a route to NHS or payer revenueValue-based procurement is live in 2026. Show a pilot or framework path to a paying system.
- 4.Match the fund to your stage and sub-sectorSpecialists like AlbionVC back clinical AI. Seed funds back consumer health. Target the right one.
How Ellty helps you land a London healthtech investor
You have the list. Now prepare your materials. Health investors ask for clinical and regulatory proof fast.
- 1.Put clinical and regulatory docs in one roomUpload outcome studies and your regulatory file. Health investors review both before any term sheet.
- 2.Lock access to patient and clinical dataRequire email before investors view clinical data. Use screenshot protection on sensitive studies.
- 3.Track who reviews your evidence packSee who opens your clinical studies versus the deck. Investors reviewing evidence are serious buyers.
What London healthtech founders ask before raising
- For seed, early pilot data is enough. For Series A, most London health VCs want a real outcome study.
- Specialists like AlbionVC if your product is clinical. Generalists work for consumer health with traction.
- Value-based procurement is live in 2026. Investors want a clear path to a paying health system.
- Before your first outreach. Have clinical and regulatory docs in an Ellty room before you email anyone.
- A wellness app with no outcome data. Investors are tired of usage metrics that don't prove health value.
- Target six to ten funds matching your stage and sub-sector. Track who opens your data room first.
